產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-EEF1G抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-EEF1G抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-EEF1G
Cat. Number:
Anti-EEF1G抗體KL-13056R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
EF-1 (elongation factor-1) is a multi-protein complex that is responsible for the delivery of aminoacyl-tRNAs to the ribosome. EF-1 gamma (elongation factor 1-gamma), also known as EEF1G or GIG35, is a 437 amino acid subunit of the EF-1 complex. Expressed in stomach, pancreas, brain, lung, kidney, intestine, liver and spleen, Anti-EEF1G抗體EF-1 gamma contains an N-terminal glutathione transferase domain which is thought to be involved in anchoring the complex to various cellular components. Additionally, EF-1 gamma may play a key role in the assembly of multiprotein complexes containing aminoacyl-tRNA synthetases. Increased expression of EF-1 gamma is associated with pancreatic cancer, suggesting a possible role for EF-1 gamma in the oncogenic transformation process.
Also known as:
2610301D06Rik; AA407312; eEF Anti-EEF1G抗體1B gamma; EEF 1G; eEF-1B gamma; EEF1G; EF 1 gamma; EF 1G; EF-1-gamma; EF1 gamma; EF1G; EF1G_HUMAN; Elongation factor 1 gamma; Elongation factor 1-gamma; Eukaryotic translation elongation factor 1 gamma; GIG 35; GIG35; MGC103354; MGC114210; MGC144723; MGC144724; MGC94929; Pancreatic tumor related protein; PRO1608; Translation elongation factor eEF 1 gamma chain.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugatedAnti-EEF1G抗體 synthetic peptide derived from human EEF1G.
●
Predicted Molecular Weight: 50kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-EEF1G抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-EEF1G抗體
Optimal working dilutions must be determined by the end user.
kl637Mu01 氨基己糖苷酶Bβ(HEXβ)多克隆抗體 Polyclonal Antibody to Hexosaminidase B Beta (HEXb)
kl637Ra01 氨基己糖苷酶Bβ(HEXβ)多克隆抗體 Polyclonal Antibody to Hexosaminidase B Beta (HEXb)
kl638Bo01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl638Hu01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl638Mu01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl638Ra01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl642Ra01 果糖二磷酸醛縮酶A(ALDOA)多克隆抗體 Polyclonal Antibody to Aldolase A, Fructose Bisphosphate (ALDOA)
kl644Hu01 CCAAT增強(qiáng)子結(jié)合蛋白α(CEBPα)多克隆抗體 Polyclonal Antibody to CCAAT/Enhancer Binding Protein Alpha (CEBPa)
kl645Hu01 晚期糖基化終末產(chǎn)物受體(AGER)多克隆抗體 Polyclonal Antibody to Advanced Glycosylation End Product Specific Receptor (AGER)
kl645Mu01 晚期糖基化終末產(chǎn)物受體(AGER)多克隆抗體 Polyclonal Antibody to Advanced Glycosylation End Product Specific Receptor (AGER)
kl646Hu01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl646Mu01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl646Ra01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl647Hu01 Smad同源物1(Smad1)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 1 (Smad1)
kl647Ra01 Smad同源物1(Smad1)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 1 (Smad1)
kl648Hu01 Smad同源物7(Smad7)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 7 (Smad7)
kl648Mu01 Smad同源物7(Smad7)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 7 (Smad7)
